Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00975585 · ClinicalTrials.gov registry record · NA

Clinical Performance Comparison of Two Contact Lenses

A NA study of Myopia, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
379
Enrollment target
20
Study locations

NCT00975585: Completed NA study of Myopia, sponsored by Johnson & Johnson Vision Care.

NCT00975585 is a NA study of Myopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 379 participants, above the 264-participant average among 90 other Myopia trials with a reported enrollment target (44% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00975585, a NA study of Myopia, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
379 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to compare the clinical performance of two contact lenses.

Primary Outcome

The overall score is the average of the total scores of each of five regions of the cornea. The minimum average score is 0 and the maximum average score is 3. Corneal surface abnormality as indicated by the severity of staining over five regions of the cornea (central, superior, inferior, nasal and temporal) was assessed by the investigator using the following scale: 0=none, 1=slight, 2=moderate, 3=severe.

Conditions Studied

Myopia

Interventions

  • DEVICE senofilcon A
  • DEVICE lotrafilcon B

Study Locations (20)

Florida

  • - Jacksonville
  • - Jacksonville
  • - Miami
  • - Winter Park

Ohio

  • - Chagrin Falls
  • - North Olmsted
  • - Warren

Massachusetts

  • - Boston
  • - Cambridge

South Dakota

  • - Chamberlain
  • - Hot Springs

Arkansas

  • - North Little Rock

California

  • - Campbell

Colorado

  • - Colorado Springs

Georgia

  • - Roswell

Trial Details

FieldValue
Enrollment Target 379 participants
Start Date 2009-08-01
Est. Completion 2009-10-01
Phase NA
Johnson & Johnson Vision Care

142 total trials

What the finished NCT00975585 record still lists

NCT00975585 is an interventional study that assigns participants to a tested intervention. The registered 379 participants enrollment target is mid-sized for trials with a published cap, above the 264-participant average among 90 other Myopia trials with a reported enrollment target (44% higher).

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which senofilcon A is the first listed.

NCT00975585 names 20 study sites across 13 states, led by Florida, Ohio, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00975585 about?

NCT00975585 is a clinical study titled "Clinical Performance Comparison of Two Contact Lenses". The purpose of this study is to compare the clinical performance of two contact lenses.

What is the current status of trial NCT00975585?

This trial is currently completed. It is a NA study. The enrollment target is 379 participants. The study started on 2009-08-01. Estimated completion is 2009-10-01.

What conditions does trial NCT00975585 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT00975585?

The interventions under investigation include: senofilcon A (DEVICE), lotrafilcon B (DEVICE).

Who is sponsoring clinical trial NCT00975585?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00975585 being conducted?

This trial has 20 study locations across Arkansas, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00975585's enrollment target sits among peer trials

379 12th of 90 higher than 79 of 90 other Myopia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04560673 · 380 participants · Phase 2

    Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

  • NCT04777357 · 380 participants · Phase 3

    A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

  • NCT04821154 · 380 participants

    Persona Revision Knee System Outcomes

  • NCT05102019 · 380 participants · NA

    Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT00975585, the US trial registry maintained by the National Library of Medicine. NCT00975585 (mid enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.